Aspirin and risk of bleeding in patients with thrombocythemia.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  American Journal of Medicine

• Publication date

  1987-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(87)90696-6PMID 3497579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Moderate doses of aspirin and risk of bleeding in renal failure.

  1986cited by this paper
• Bleeding and thrombosis in the myeloproliferative disorders.

  1984cited by this paper
• Intensive cytoreductive regimen and autologous bone marrow transplantation in leukemia. Present status and the future. A review.

  1983cited by this paper
• Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.

  1983cited by this paper
• Uncontrolled thrombocytosis in chronic myeloproliferative disorders

  1982cited by this paper
• Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.

  1982cited by this paper
• Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects.

  1980cited by this paper
• Abnormal Aggregation and Increased Size of Platelets in Myeloproliferative Disorders

  1980cited by this paper
• The Post‐Aspirin Bleeding Time: a Screening Test for Evaluating Haemostatic Disorders

  1979cited by this paper
• Rapid, Sensitive Microassay for Platelet 5HT

  1974cited by this paper
• Letter: Rapid, sensitive microassay for platelet 5HT.

  1974cited by this paper
• Letter: Type-A hepatitis.

  1974cited by this paper
• The bleeding time as a screening test for evaluation of platelet function.

  1972cited by this paper
• The aggregation of blood platelets

  1963cited by this paper

• Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?

  2023cites this paper
• Evaluation of platelet function in essential thrombocythemia under different analytical conditions

  2020cites this paper
• Dental Management of Patients Undergoing Antithrombotic Therapy.

  2020cites this paper
• Aspirin in low-risk essential thrombocythemia, not so simple after all?

  2011cites this paper
• Safety and Antithrombotic Efficacy of Moderate Platelet Count Reduction by Thrombopoietin Inhibition in Primates

  2010cites this paper
• Characterization of prothrombotic pathways in vivo, and discovery of potential new therapies for pathological blood coagulation

  2009cites this paper
• Extreme thrombocytosis--an unusual presentation of inflammatory bowel disease.

  2008cites this paper
• Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with Essential Thrombocythemia

  2007cites this paper
• Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.

  2006cites this paper
• The Paradox of Platelet Activation and Impaired Function: Platelet-von Willebrand Factor Interactions, and the Etiology of Thrombotic and Hemorrhagic Manifestations in Essential Thrombocythemia and Polycythemia Vera

  2006cites this paper
• Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.

  2006cites this paper
• Hematologic Disorders and Ischemic Stroke

  2005cites this paper
• Acroparesthesia and acral arterial occlusions as first manifestations of essential thrombocythemia.

  2005cites this paper
• A Selective Review

  2005cites this paper
• Thrombocytosis.

  2004cites this paper
• current concepts Thrombocytosis

  2004cites this paper
• Antiplatelet drugs : is there a surgical risk?

  2002cites this paper
• Les antiplaquettaires : Y a t-il un risque opératoire?

  2002cites this paper
• Neurologic manifestations of hematologic disorders.

  2002cites this paper
• THE OPTIMAL MANAGEMENT OF POLYCYTHAEMIA VERA

  2002cites this paper
• Excessive prolongation of the Ivy bleeding time after aspirin in essential thrombocythemia is also demonstrable in vitro in the high shear stress system PFA-100

  2002cites this paper
• Thrombocytosis and thrombocythemia.

  2001cites this paper
• Essential thrombocythemia in children.

  1999cites this paper
• Effects of nonsteroidal anti-inflammatory therapy on platelets.

  1999cites this paper
• Essential thrombocythaemia in children

  1999cites this paper
• Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: Role of the lipoxygenase pathway

  1998cites this paper
• Treatment of polycythaemia vera and essential thrombocythaemia.

  1998cites this paper
• 4 Treatment of polycythaemia vera and essential thrombocythaemia

  1998cites this paper
• Contribution of platelets to PAI-1 concentration in plasma of patients with primary and secondary thrombocytosis

  1997cites this paper
• Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma

  1997cites this paper
• Hämorheologische Erkrankungen: Thrombozytose — Polyzythämie — lokale Thrombose — Mikroembolie

  1997cites this paper
• Aspirin in Essential Thrombocythemia: Status Quo and Quo Vadis

  1997cites this paper
• Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases.

  1997cites this paper
• Hamostasestorungen bei myeloproliferativen Erkrankungen

  1996cites this paper
• Primary thrombocythemia and pregnancy: Treatment and outcome in fifteen cases

  1996cites this paper
• Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes.

  1996cites this paper
• Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.

  1996cites this paper
• The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count

  1996cites this paper
• Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment.

  1995cites this paper
• Increased Thromboxane Biosynthesis in Essential Thrombocythemia

  1995cites this paper
• Thrombocytémie essentielle

  1995cites this paper
• Lipoxygenase Deficiency in Primary Thrombocythemia Is not a True Deficiency

  1994cites this paper
• [Essential thrombocythemia. Clinical significance, diagnosis and therapy].

  1993cites this paper
• Nonatheromatous arterial thrombosis.

  1993cites this paper
• Primary thrombocythemia: diagnosis, clinical manifestations and management

  1993cites this paper
• Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders

  1992cites this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1992. Repeated bouts of hematochezia in an 80-year-old hypertensive man.

  1992cites this paper
• Benign familial thrombocytosis

  1991cites this paper
• Essential thrombocythemia in a child: management with anagrelide.

  1991cites this paper
• Hematologic disorders and ischemic stroke. A selective review.

  1990cites this paper
• Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

  1990cites this paper
• Thrombocytosis and thrombocythemia.

  1990cites this paper
• Hematopoietic emergencies.

  1989cites this paper